An	O
enhancer	B-ENHANCER
20	I-ENHANCER
kilobases	I-ENHANCER
upstream	I-ENHANCER
of	I-ENHANCER
the	I-ENHANCER
human	I-ENHANCER
receptor	I-ENHANCER
activator	I-ENHANCER
of	I-ENHANCER
nuclear	I-ENHANCER
factor	I-ENHANCER
-	I-ENHANCER
kappaB	I-ENHANCER
ligand	I-ENHANCER
gene	E-ENHANCER
mediates	O
dominant	O
activation	O
by	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
.	O


Receptor	O
activator	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
ligand	O
(	O
RANKL	O
)	O
is	O
a	O
TNF	O
-	O
like	O
factor	O
that	O
is	O
both	O
produced	O
by	O
osteoblasts	O
,	O
mesenchymal	O
cells	O
,	O
and	O
activated	O
T	O
cells	O
and	O
required	O
for	O
osteoclast	O
maturation	O
and	O
survival	O
.	O


The	O
gene	O
is	O
up	O
-	O
regulated	O
by	O
the	O
two	O
primary	O
calcemic	O
hormones	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
]	O
and	O
PTH	O
.	O


Previous	O
studies	O
have	O
indicated	O
that	O
five	B-ENHANCER
enhancer	I-ENHANCER
regions	I-ENHANCER
located	I-ENHANCER
significantly	I-ENHANCER
upstream	I-ENHANCER
of	I-ENHANCER
the	I-ENHANCER
mouse	I-ENHANCER
Rankl	I-ENHANCER
transcriptional	I-ENHANCER
start	I-ENHANCER
site	E-ENHANCER
mediate	O
up	O
-	O
regulation	O
by	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
and	O
PTH	O
.	O


The	O
most	O
distal	O
of	O
these	O
,	O
termed	O
mRLD5	S-ENHANCER
,	O
is	O
highly	O
conserved	O
in	O
the	O
human	O
gene	O
at	B-ENHANCER
-	I-ENHANCER
96	I-ENHANCER
kb	E-ENHANCER
where	O
it	O
was	O
also	O
shown	O
to	O
be	O
functionally	O
active	O
.	O
Four	B-ENHANCER
additional	I-ENHANCER
mouse	I-ENHANCER
Rankl	I-ENHANCER
upstream	I-ENHANCER
enhancers	E-ENHANCER
are	O
also	O
highly	O
conserved	O
in	O
the	O
human	O
gene	O
at	O
-	B-ENHANCER
20	E-ENHANCER
,	O
-	B-ENHANCER
25	E-ENHANCER
,	O
-	B-ENHANCER
75	E-ENHANCER
,	O
and	O
-	B-ENHANCER
87	I-ENHANCER
kb	E-ENHANCER
.	O


In	O
the	O
present	O
studies	O
,	O
we	O
characterized	O
the	O
activity	O
of	O
these	O
regions	O
,	O
explored	O
their	O
capacity	O
to	O
mediate	O
the	O
actions	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
,	O
and	O
identified	O
the	O
vitamin	O
D	O
response	O
elements	O
contained	O
within	O
the	B-ENHANCER
two	I-ENHANCER
most	I-ENHANCER
proximal	I-ENHANCER
segments	E-ENHANCER
.	O


Interestingly	O
,	O
whereas	O
the	B-ENHANCER
most	I-ENHANCER
distal	I-ENHANCER
of	I-ENHANCER
the	I-ENHANCER
five	I-ENHANCER
enhancers	E-ENHANCER
is	O
the	O
dominant	O
mediator	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
activity	O
in	O
the	O
mouse	O
Rankl	O
gene	O
,	O
that	O
role	O
in	O
the	O
human	O
gene	O
is	O
manifested	O
by	O
the	O
most	B-ENHANCER
proximal	I-ENHANCER
element	I-ENHANCER
at	I-ENHANCER
-	I-ENHANCER
20	I-ENHANCER
kb	E-ENHANCER
.	O


Importantly	O
,	O
activity	O
at	O
this	O
region	O
in	O
response	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
was	O
associated	O
with	O
a	O
significant	O
increase	O
in	O
histone	O
acetylation	O
as	O
well	O
as	O
the	O
enhanced	O
recruitment	O
of	O
RNA	O
polymerase	O
II	O
.	O


Both	O
likely	O
reflect	O
the	O
primary	O
role	O
of	O
this	O
enhancer	S-ENHANCER
in	O
human	O
RANKL	O
gene	O
expression	O
.	O


Our	O
studies	O
confirm	O
the	O
complex	O
nature	O
of	O
RANKL	O
regulation	O
and	O
indicate	O
that	O
although	O
the	O
five	B-ENHANCER
enhancers	E-ENHANCER
are	O
evolutionarily	O
conserved	O
across	O
several	O
species	O
,	O
their	O
relative	O
contributions	O
to	O
RANKL	O
expression	O
in	O
response	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
may	O
be	O
different	O
.	O
